Key result
PAD genetic discovery lags behind CHD, limited by clinical and genetic heterogeneity.
Answers are grounded in this paper and cite their sources.
Several risk factors for atherosclerotic peripheral arterial disease (PAD), such as dyslipidemia, diabetes mellitus, and hypertension, are heritable. However, predisposition to PAD may be influenced by genetic variants acting independently of these risk factors. Identification of such genetic variants will provide insights into underlying pathophysiologic mechanisms and facilitate the development of novel diagnostic and therapeutic approaches. In contrast to coronary heart disease, relatively few genetic variants that influence susceptibility to PAD have been discovered. This may be, in part, because of greater clinical and genetic heterogeneity in PAD. In this review, we (1) provide an update on the current state of knowledge about the genetic basis of PAD, including results of family studies and candidate gene, linkage as well as genome-wide association studies; (2) highlight the challenges in investigating the genetic basis of PAD and possible strategies to overcome these challenges; and (3) discuss the potential of genome sequencing, RNA sequencing, differential gene expression, epigenetic profiling, and systems biology in increasing our understanding of the molecular genetics of PAD.
No takes yet. Share an insight, caveat, or question.
Kullo et al. (2015) conducted a review in Atherosclerotic peripheral arterial disease (PAD). Genetic variants and molecular profiling was evaluated. Genetic variants influencing peripheral arterial disease susceptibility remain largely undiscovered compared to coronary heart disease, partly due to clinical and genetic heterogeneity.
Synapse has enriched 10 related papers. Consider them for comparative context: